Questions? Feedback? powered by Olark live chat software

Stryker Announces New Settlement of Rejuvenate and ABGII Cases

Stryker Recalls LFIT™ Anatomic CoCr V40™ Femoral Heads

On December 19, 2016, Stryker announced a second round of settlement involving patients who received Rejuvenate or ABG II modular hip replacement systems and were then required to undergo a revision surgery to remove these defective hip components. The settlement includes a base award amount of $300,000.00 to each qualifying claimant who has undergone revision surgery before December 19, 2016, subject to certain potential reductions. Claimants may also receive additional compensation if they suffered certain categories of injury set-forth in the Settlement Agreement.
The Settlement Agreement provides various deadlines for participation in this settlement. Failure to act within these deadlines will result in the loss of valuable legal rights. Therefore, if you or a loved one received a Stryker Rejuvenate or ABGII hip implant system, and had to undergo another surgery to remove and replace these components, it is important that you contact us immediately. Meshbesher & Spence attorneys Tony Nemo and Genevieve Zimmerman were appointed by the federal court to help lead the litigation against Stryker, and are available to meet with you to discuss your rights in this settlement. Please call us today for a free consultation.

For more information please see settlement agreement below.

2016-settlement-agreement

 

 

 

Post a Comment

Your email is never published nor shared. Required fields are marked *